Literature DB >> 9398800

Differential effects of deoxycholic acid on proliferation of neoplastic and differentiated colonocytes in vitro.

L P Peiffer1, D J Peters, T J McGarrity.   

Abstract

The secondary bile acid deoxycholic acid is believed to be a promoter of large bowel cancer, in part by inducing colonic epithelial proliferation. The effects of deoxycholic acid on [3H]thymidine incorporation by the human colon cancer cell line HT29 and two differentiated subclones were measured and compared. The subclone HT29-C1 has features of mature absorptive cells and HT29-N2 cells secrete mucus under cholinergic control. The three cell lines were treated with deoxycholic acid (DCA) at concentrations of 0, 5, 10, 50, 100, 150, and 300 microM for 3, 6, 9, 15, 24, and 48 hr. A significant increase in proliferation was noted in HT29 cells only at 6 hr with 5 and 10 microM deoxycholic acid. Neither the subclone HT29-C1, nor HT29-N2 cells exhibited significant change in [3H]thymidine incorporation with DCA at these concentrations or time points. Higher doses of deoxycholic acid above 50 microM and duration of exposure greater than 24 hr were cytotoxic to all three cell lines. The proliferative effects of DCA in HT29 cells were not paralleled by changes in protein kinase C activity or protein kinase C isoform expression. Quantitative and qualitative differences in PKC isoform expression were not noted in the three cell lines used in this study. The proliferative effects of DCA on HT29 cells appear to be independent of the PKC signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398800     DOI: 10.1023/a:1018806431866

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  39 in total

1.  Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women.

Authors:  W C Willett; M J Stampfer; G A Colditz; B A Rosner; F E Speizer
Journal:  N Engl J Med       Date:  1990-12-13       Impact factor: 91.245

2.  Decreased levels of protein kinase C enzyme activity and protein kinase C mRNA in primary colon tumors.

Authors:  M F Levy; J Pocsidio; J G Guillem; K Forde; P LoGerfo; I B Weinstein
Journal:  Dis Colon Rectum       Date:  1993-10       Impact factor: 4.585

3.  Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: influence of amount and source of dietary fat.

Authors:  B S Reddy; Y Maeura
Journal:  J Natl Cancer Inst       Date:  1984-03       Impact factor: 13.506

4.  Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation by unsaturated fatty acids.

Authors:  P A Craven; F R DeRubertis
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

5.  The regulation of protein kinase C by chenodeoxycholate, deoxycholate and several structurally related bile acids.

Authors:  C J Fitzer; C A O'Brian; J G Guillem; I B Weinstein
Journal:  Carcinogenesis       Date:  1987-02       Impact factor: 4.944

6.  Five of six protein kinase C isoenzymes present in normal mucosa show reduced protein levels during tumor development in the human colon.

Authors:  P Kahl-Rainer; J Karner-Hanusch; W Weiss; B Marian
Journal:  Carcinogenesis       Date:  1994-04       Impact factor: 4.944

7.  Bile acid receptors in colorectal cancer.

Authors:  J Summerton; M Flynn; T Cooke; I Taylor
Journal:  Br J Surg       Date:  1983-09       Impact factor: 6.939

8.  Fecal free and conjugated bile acids and neutral sterols in vegetarians, omnivores, and patients with colorectal cancer.

Authors:  J T Korpela; H Adlercreutz; M J Turunen
Journal:  Scand J Gastroenterol       Date:  1988-04       Impact factor: 2.423

9.  Differential expression of protein kinase C isoforms in human colorectal cancers.

Authors:  M Kuranami; C T Powell; H Hug; Z Zeng; A M Cohen; J G Guillem
Journal:  J Surg Res       Date:  1995-02       Impact factor: 2.192

10.  Changes in villin synthesis and subcellular distribution during intestinal differentiation of HT29-18 clones.

Authors:  B Dudouet; S Robine; C Huet; C Sahuquillo-Merino; L Blair; E Coudrier; D Louvard
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

View more
  8 in total

1.  Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.

Authors:  Anan H Said; Shien Hu; Ameer Abutaleb; Tonya Watkins; Kunrong Cheng; Ahmed Chahdi; Panjamurthy Kuppusamy; Neeraj Saxena; Guofeng Xie; Jean-Pierre Raufman
Journal:  Biochem J       Date:  2017-02-20       Impact factor: 3.857

2.  Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness.

Authors:  Rama Pai; Andrzej S Tarnawski; Teresa Tran
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

3.  Co-treatment with deoxycholic acid and azoxymethane accelerates secretion of HMGB1 in IEC6 intestinal epithelial cells.

Authors:  K Fujii; Y Luo; T Sasahira; A Denda; H Ohmori; H Kuniyasu
Journal:  Cell Prolif       Date:  2009-07-06       Impact factor: 6.831

4.  Sphingomyelin protects against apoptosis and hyperproliferation induced by deoxycholate: potential implications for colon cancer.

Authors:  A Moschetta; P Portincasa; K J van Erpecum; L Debellis; G P Vanberge-Henegouwen; G Palasciano
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

5.  Effects of DCA on Cell Cycle Proteins in Colonocytes.

Authors:  Yun-Hyung Ha; Dong-Guk Park
Journal:  J Korean Soc Coloproctol       Date:  2010-08-31

6.  Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4.

Authors:  Eleonóra Gál; Zoltán Veréb; Lajos Kemény; Dávid Rakk; András Szekeres; Eszter Becskeházi; László Tiszlavicz; Tamás Takács; László Czakó; Péter Hegyi; Viktória Venglovecz
Journal:  Sci Rep       Date:  2020-12-16       Impact factor: 4.379

7.  Cholecystectomy promotes the development of colorectal cancer by the alternation of bile acid metabolism and the gut microbiota.

Authors:  Xi Jiang; Zhongxiu Jiang; Qi Cheng; Wei Sun; Min Jiang; Yan Sun
Journal:  Front Med (Lausanne)       Date:  2022-09-23

8.  Prevention of N-methylnitrosourea-induced colon tumorigenesis by ursodeoxycholic acid in F344 rats.

Authors:  T Narisawa; Y Fukaura; K Terada; H Sekiguchi
Journal:  Jpn J Cancer Res       Date:  1998-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.